# Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure

> **NCT07704424** · NA · RECRUITING · sponsor: **Shenzhen Core Medical Technology CO.,LTD.** · enrollment: 6 (estimated)

## Conditions studied

- Right Heart Failure

## Interventions

- **DEVICE:** CorVad Percutaneous Ventricular Assist System

## Key facts

- **NCT ID:** NCT07704424
- **Lead sponsor:** Shenzhen Core Medical Technology CO.,LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-02
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-02-28
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07704424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07704424, "Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07704424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*